Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share (Tables)

v3.24.1.u1
Earnings Per Share (Tables)
9 Months Ended
Mar. 31, 2024
Notes Tables  
Schedule of the calculation of basic and diluted earnings per share

The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Quarter Ended

​

Nine Months Ended

​

​

March 31, 

​

March 31, 

​

    

2024

    

2023

​

2024

    

2023

Earnings per share – basic:

​

​

​

​

​

​

​

​

​

​

​

​

Net earnings, including noncontrolling interest

​

$

49,059

 

$

70,218

​

$

127,517

 

$

209,958

Less net earnings (loss) attributable to noncontrolling interest

​

​

—

 

​

—

​

​

—

 

​

179

Net earnings attributable to Bio-Techne

​

$

49,059

​

$

70,218

​

$

127,517

​

$

209,779

Income allocated to participating securities

​

 

(5)

​

 

(16)

​

 

(24)

​

 

(52)

Income available to common shareholders

​

$

49,054

​

$

70,202

​

$

127,493

​

$

209,727

Weighted-average shares outstanding – basic

​

 

157,309

​

 

157,311

​

 

157,655

​

 

157,071

Earnings per share – basic

​

$

0.31

​

$

0.45

​

$

0.81

​

$

1.34

​

​

​

​

​

​

​

​

​

​

​

​

​

Earnings per share – diluted:

​

 

  

​

 

  

​

 

  

​

 

  

Net earnings, including noncontrolling interest

​

$

49,059

​

$

70,218

​

$

127,517

​

$

209,958

Less net earnings (loss) attributable to noncontrolling interest

​

​

—

​

​

—

​

​

—

​

​

179

Net earnings attributable to Bio-Techne

​

$

49,059

​

$

70,218

​

$

127,517

​

$

209,779

Income allocated to participating securities

​

 

(5)

​

 

(16)

​

 

(24)

​

 

(52)

Income available to common shareholders

​

$

49,054

​

$

70,202

​

$

127,493

​

$

209,727

Weighted-average shares outstanding – basic

​

 

157,309

​

 

157,311

​

 

157,655

​

 

157,071

Dilutive effect of stock options and restricted stock units

​

 

3,187

​

 

4,304

​

 

3,162

​

 

4,697

Weighted-average common shares outstanding – diluted

​

 

160,496

​

 

161,615

​

 

160,817

​

 

161,768

Earnings per share – diluted

​

$

0.31

​

$

0.43

​

$

0.79

​

$

1.30